Link here. July 23rd, 2014. Results published today in the prestigious Journal of Allergy and Clinical Immunology (JACI) announce a ground-breaking increase in adherence with asthma medications for patients provided with a novel device called the Smartinhaler, manufactured by digital health company Nexus6 Ltd. The research was conducted by the highly regarded Woolcock Institute of Medical Research […]
Released : 10 July 2014 RNS Number : 8968L Link here. REX to exhibit at the Hamlyn Symposium on Medical Robots Rex Bionics plc (AIM: RXB), the developer and manufacturer of REX products: hands-free robotic exoskeletons for use by wheelchair users, announces that it will be exhibiting at the 7th Hamlyn Symposium on Medical Robots, at the […]
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2014-07-10 18:09:412018-01-06 18:10:09REX to exhibit at the Hamlyn Symposium on Medical Robots
Friday June 27, 2014. The National Business Review article link here. A local sleeper medical technology company has ambitious plans to move into commercial production, and won’t rule out an initial public offering. Reporter David Williams looks into how the up and coming tech company are developing a smart device to remotely monitor how people with asthma and other […]
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2014-06-27 18:11:352018-01-06 18:12:00Nexus6 – Sleeper medical technology company stirs.
MELBOURNE, Australia – June 05, 2014 – Nexvet Biopharma, a leading veterinary biologic drug developer, today announced the oral presentation of data related to clinical development of NV-01, a … Down load article here.
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2014-06-05 18:10:162018-01-06 18:10:37Nexvet to present key data on use of species-specific monoclonal antibodies in management of chronic pain in dogs
Nexus6 Ltd, has received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) for its new SmartTouch inhaler monitoring device. June 3rd, 2014. Link here. It is well known that it is difficult for patients to remember to take daily preventative medications over a long term as required for the management of many chronic […]
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2014-06-03 18:01:112018-01-06 18:01:43Nexus6 Receives FDA Clearance for Latest Smartinhaler
NZX & Media Release 30 May 2014. Link here. Financial results for the year to 31 March 2014 Highlights: • Significant new squalene sales contract demonstrates the benefits of a secure raw material supply • Making good progress on the new refined fish oil plant in Nelson • Financially well positioned with $5.2m of cash on hand […]
RICHMOND, VA, US, LJUBLJANA, SLOVENIA and SYDNEY, AUSTRALIA, May 22, 2014 Link here. AmpliPhi BioSciences Corporation (OTCBB: APHB), the global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, announced today that Wendy Johnson has been appointed to its Board of Directors effective May 19, 2014. Ms. Johnson will stand for election […]
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2014-05-22 18:10:442018-01-06 18:11:25AmpliPhi Announces Appointment of New Board Member
Link here. RICHMOND, VA, US, LJUBLJANA, SLOVENIA and SYDNEY, AUSTRALIA, May 22, 2014 –AmpliPhi BioSciences Corporation (OTCBB: APHB), the global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, announced today that Wendy Johnson has been appointed to its Board of Directors effective May 19, 2014. Ms. Johnson will stand for election to […]
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2014-05-22 18:01:512018-01-06 18:02:13AmpliPhi Announces Appointment of New Board Member – Wendy Johnson
Nexus6’s Smartinhaler Dramatically Improves Medication Adherence
/in Adherium, Portfolio CompaniesLink here. July 23rd, 2014. Results published today in the prestigious Journal of Allergy and Clinical Immunology (JACI) announce a ground-breaking increase in adherence with asthma medications for patients provided with a novel device called the Smartinhaler, manufactured by digital health company Nexus6 Ltd. The research was conducted by the highly regarded Woolcock Institute of Medical Research […]
REX to exhibit at the Hamlyn Symposium on Medical Robots
/in Portfolio Companies, Rex BionicsReleased : 10 July 2014 RNS Number : 8968L Link here. REX to exhibit at the Hamlyn Symposium on Medical Robots Rex Bionics plc (AIM: RXB), the developer and manufacturer of REX products: hands-free robotic exoskeletons for use by wheelchair users, announces that it will be exhibiting at the 7th Hamlyn Symposium on Medical Robots, at the […]
Nexus6 – Sleeper medical technology company stirs.
/in Adherium, Portfolio CompaniesFriday June 27, 2014. The National Business Review article link here. A local sleeper medical technology company has ambitious plans to move into commercial production, and won’t rule out an initial public offering. Reporter David Williams looks into how the up and coming tech company are developing a smart device to remotely monitor how people with asthma and other […]
SeaDragon Investor Presentation June 2014
/in Portfolio Companies, SeaDragonLink here. Presentation overview: • FY2014 Financial Review • The Market / Industry Overview • Business Update
Avita Medical – Positive ReCell repigmentation trial results
/in Avita Medical, Portfolio CompaniesAustralia, 11 June 2014. ASX announcement here.
Nexvet to present key data on use of species-specific monoclonal antibodies in management of chronic pain in dogs
/in Pharmamark, Portfolio CompaniesMELBOURNE, Australia – June 05, 2014 – Nexvet Biopharma, a leading veterinary biologic drug developer, today announced the oral presentation of data related to clinical development of NV-01, a … Down load article here.
Nexus6 Receives FDA Clearance for Latest Smartinhaler
/in Adherium, Portfolio CompaniesNexus6 Ltd, has received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) for its new SmartTouch inhaler monitoring device. June 3rd, 2014. Link here. It is well known that it is difficult for patients to remember to take daily preventative medications over a long term as required for the management of many chronic […]
SeaDragon poised for significant growth
/in Portfolio Companies, SeaDragonNZX & Media Release 30 May 2014. Link here. Financial results for the year to 31 March 2014 Highlights: • Significant new squalene sales contract demonstrates the benefits of a secure raw material supply • Making good progress on the new refined fish oil plant in Nelson • Financially well positioned with $5.2m of cash on hand […]
AmpliPhi Announces Appointment of New Board Member
/in Armata Pharmaceuticals, Portfolio CompaniesRICHMOND, VA, US, LJUBLJANA, SLOVENIA and SYDNEY, AUSTRALIA, May 22, 2014 Link here. AmpliPhi BioSciences Corporation (OTCBB: APHB), the global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, announced today that Wendy Johnson has been appointed to its Board of Directors effective May 19, 2014. Ms. Johnson will stand for election […]
AmpliPhi Announces Appointment of New Board Member – Wendy Johnson
/in Armata Pharmaceuticals, Portfolio CompaniesLink here. RICHMOND, VA, US, LJUBLJANA, SLOVENIA and SYDNEY, AUSTRALIA, May 22, 2014 –AmpliPhi BioSciences Corporation (OTCBB: APHB), the global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, announced today that Wendy Johnson has been appointed to its Board of Directors effective May 19, 2014. Ms. Johnson will stand for election to […]